Ewan R. Pearson

机构：University of Dundee, Ninewells Hospital, Genomics (United Kingdom) · ORCID：0000-0001-9237-8585

发表论文 560 篇 · 总被引 27711 次 · h-index 82

代表论文

• GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects (2026 · Journal of Clinical Investigation · 被引 8)
• Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection (2025 · Diabetologia · 被引 4)
• One‐year usage patterns of SGLT ‐2 inhibitors and GLP ‐1 receptor agonists in individuals with type 2 diabetes in a real‐world population (2025 · Diabetes Obesity and Metabolism · 被引 4)
• Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study (2025 · The Lancet Regional Health - Europe · 被引 2)
• Participant characteristics in the effectiveness of lifestyle interventions to optimize gestational weight gain: a systematic review and meta-analysis (2025 · Communications Medicine · 被引 2)
• Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data (2026 · The Lancet Primary Care · 被引 1)